Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03181373
Other study ID # CHU-328
Secondary ID
Status Active, not recruiting
Phase N/A
First received May 9, 2017
Last updated June 7, 2017
Start date September 26, 2014
Est. completion date December 2018

Study information

Verified date May 2017
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Longitudinal descriptive study of a cohort of twenty brain-damaged patients for a two years period.


Description:

The following data are collected in 3 months, 12 months then 24 months after the accident with followed data collection :

- Clinical, neuropsychological assessments

- Diffusion magnetic resonance imaging (MRI) for the reconstruction of anatomical pathways

- Functional imaging data.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 20
Est. completion date December 2018
Est. primary completion date July 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Adult patients, over the age of 18.

- Mild traumatic brain injury (Initial Glasgow score between 9 and 12)

- Severe brain injury (Initial Glasgow score between 3 and 8),

- Diffuse axonal injury and/or focal lesions.

Exclusion Criteria:

- Patients with MRI contraindications,

- Antecedents of brain lesions,

- Important lesions of the lobes and cortex on cerebral CT,

- Anoxic lesions related to cardiorespiratory arrest,

- Must be able to perform neuropsychological tests,

- Visual and auditory impairments.

- Aphasia

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cognitive rehabilitation program
Rehabilitation

Locations

Country Name City State
France CHU Clermont-Ferrand Clermont-Ferrand Auvergne

Sponsors (5)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand APF, Clementel, LADAPT, Maurice Gantchoula

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Baseline standardized volume of the white matter fascicles determined on the "iplan" software. Baseline measured at 3 months after brain traumatic injury. at 3, 12 and 24 months
Secondary Measure of the volume of activations clusters during functional MRI for attention, motor, working memory, language tasks. at 3, 12 and 24 months
Secondary Location of activation clusters during functional MRI for attention, motor, working memory, language tasks. at 3, 12 and 24 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT01796886 - Performance Evaluation of Pupillary Reactivity in Monitoring of Brain-damaged Patients in Intensive Care N/A